Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ervin Ascic

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Current Opinion in Genetics & Development|December 25, 2024
Transcription factor-mediated reprogramming to antigen-presenting cellsErvin Ascic, Carlos-Filipe Pereira
Journal of Visualized Experiments : Jove|August 18, 2025
Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like CellsErvin Ascic, Gaia Fontanari, Maria Thrasyvoulou, et al.
Bio-Protocol|November 29, 2023
Reprogramming Cancer Cells to Antigen-presenting CellsAlexandra G Ferreira, Olga Zimmermannova, Ilia Kurochkin, et al.
Immunity|August 30, 2025
Anchored screening identifies transcription factor blueprints underlying dendritic cell diversity and subset-specific anti-tumor immunityLuís Henriques-Oliveira, Abigail R Altman, Ilia Kurochkin, et al.
Science (New York, N.Y.)|September 5, 2024
In vivo dendritic cell reprogramming for cancer immunotherapyErvin Ascic, Fritiof Åkerström, Malavika Sreekumar Nair, et al.
Science Immunology|July 7, 2023
Restoring tumor immunogenicity with dendritic cell reprogrammingOlga Zimmermannova, Alexandra G Ferreira, Ervin Ascic, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Current Opinion in Genetics & Development|December 25, 2024
Transcription factor-mediated reprogramming to antigen-presenting cellsErvin Ascic, Carlos-Filipe Pereira
Journal of Visualized Experiments : Jove|August 18, 2025
Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like CellsErvin Ascic, Gaia Fontanari, Maria Thrasyvoulou, et al.
Bio-Protocol|November 29, 2023
Reprogramming Cancer Cells to Antigen-presenting CellsAlexandra G Ferreira, Olga Zimmermannova, Ilia Kurochkin, et al.
Immunity|August 30, 2025
Anchored screening identifies transcription factor blueprints underlying dendritic cell diversity and subset-specific anti-tumor immunityLuís Henriques-Oliveira, Abigail R Altman, Ilia Kurochkin, et al.
Science (New York, N.Y.)|September 5, 2024
In vivo dendritic cell reprogramming for cancer immunotherapyErvin Ascic, Fritiof Åkerström, Malavika Sreekumar Nair, et al.
Science Immunology|July 7, 2023
Restoring tumor immunogenicity with dendritic cell reprogrammingOlga Zimmermannova, Alexandra G Ferreira, Ervin Ascic, et al.
Pageof 1